{
    "clinical_study": {
        "@rank": "35204", 
        "arm_group": [
            {
                "arm_group_label": "Ketamine", 
                "arm_group_type": "Experimental", 
                "description": "Ketamine infused at 0.25 mg/kg/hour."
            }, 
            {
                "arm_group_label": "Lidocaine", 
                "arm_group_type": "Experimental", 
                "description": "Lidocaine infused at 0.5 mg/kg/hour."
            }, 
            {
                "arm_group_label": "Ketamine and Lidocaine", 
                "arm_group_type": "Experimental", 
                "description": "Ketamine infused at 0.25 mg/kg/hour along with lidocaine at 0.5 mg/kg/hour"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo (saline) given to compare usual treatment against active agents in post operative pain management."
            }
        ], 
        "brief_summary": {
            "textblock": "This study has been designed as a controlled clinical trial to evaluate the efficacy of\n      brief lidocaine infusion, brief ketamine infusion and a lidocaine/ketamine combined infusion\n      when added to conventional opioid therapy following major spine surgery, as well as to\n      evaluate the effects of the lidocaine/ketamine pain protocol on the feasibility of\n      performing routine intraoperative neurophysiology during spine surgery in adults and\n      determine whether this infusion protocol is compatible with intraoperative neurophysiology\n      on spine surgery patients. If one or more of the approaches is confirmed as efficacious and\n      safe, it could have a significant impact on the routine management of postoperative pain in\n      this context."
        }, 
        "brief_title": "Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Postoperative Pain", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Male and Female >/= 18 years of age Patients undergoing first-time fusion surgery or\n        surgery to revise a prior fusion Able to read, write and speak in English, and able to\n        give informed consent for the study\n\n        Exclusion Criteria:\n\n        Any disease associated with major organ dysfunction renal dysfunction hepatic dysfunction\n        cardiac dysfunction"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983020", 
            "org_study_id": "IRB 073-10"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Lidocaine", 
                    "Ketamine and Lidocaine"
                ], 
                "intervention_name": "Lidocaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Ketamine", 
                    "Ketamine and Lidocaine"
                ], 
                "intervention_name": "Ketamine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ketamine", 
                "Lidocaine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New york", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10003"
                }, 
                "name": "Beth Israel Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Randomized Double Blind Comparison of Peri-Operative Standard Analgesia With Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery", 
        "overall_official": {
            "affiliation": "Beth Israel Medical Center", 
            "last_name": "Ronald Kaplan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome will be average pain intensity at rest on postoperative day 1 - 3.", 
            "measure": "Pain Intensity", 
            "safety_issue": "No", 
            "time_frame": "postoperative day 1 - 3"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983020"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Beth Israel Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beth Israel Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}